Anemia Industry, July 2014 Market Reports from Top Publishers

You might be interested in: nucleic acid testing, therapeutics, chemotherapy, more »


 
1-10 of 34 reports for Anemia

 Congenital Hypoplastic Anemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Congenital Hypoplastic Anemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... Reasons to buy - evaluate the marketing status and exclusivity details of congenital hypoplastic anemia key products to exploit opportunities for generic drug development opportunities. - Identify ...

 Pernicious Anemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Pernicious Anemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... Of pernicious anemia key products to exploit opportunities for generic drug development opportunities. - Identify and understand important and diverse types of therapeutics under phase iii development ...

 Renal Anemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Renal Anemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... To exploit opportunities for generic drug development opportunities. - Identify and understand important and diverse types of therapeutics under phase iii development for renal anemia. - Design ...

 Megaloblastic Anemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Megaloblastic Anemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... Evaluate the marketing status and exclusivity details of megaloblastic anemia key products to exploit opportunities for generic drug development opportunities. - Identify and understand important ...

 Aplastic Anemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Aplastic Anemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... Of aplastic anemia key products to exploit opportunities for generic drug development opportunities. - Identify and understand important and diverse types of therapeutics under phase iii development ...

 Refractory Anemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Refractory Anemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

... Of refractory anemia key products to exploit opportunities for generic drug development opportunities. - Identify and understand important and diverse types of therapeutics under phase iii development ...

 Iron Deficiency Anemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Iron Deficiency Anemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

... Status and exclusivity details of iron deficiency anemia key products to exploit opportunities for generic drug development opportunities. - Identify and understand important and diverse types ...

 Anemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Anemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

... Reasons to buy - evaluate the marketing status and exclusivity details of anemia key products to exploit opportunities for generic drug development opportunities. - Identify and understand important ...

 Acquired (Autoimmune) Hemolytic Anemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Acquired (Autoimmune) Hemolytic Anemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • June 2014
  • by Delve Insight

... anemia key products to exploit opportunities for generic drug development opportunities. - Identify and understand important and diverse types of therapeutics under phase iii development for acquired ...

Aplastic Anemia - Pipeline Review, H1 2014

Aplastic Anemia - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • May 2014
  • by Global Markets Direct

... A snapshot of the global therapeutic landscape of aplastic anemia- the report reviews key pipeline products under drug profile section which includes, product description, moa and r&d brief, licensing ...

About 2 200 reports for Anemia

Download Unlimited Documents from Trusted Public Sources

Pathology Description in Pakistan

  • Prevalence of Anemia in Pregnant Women in District Karak,
  • November 2013
    7 pages
  • Anemia  

  • Pakistan  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.